Therapeutics

Top Story

Clinicians welcome FDA’s approval of Pataday OTC

February 26, 2020
Meeting News

Speaker: Lowering IOP only proven glaucoma treatment

February 20, 2020
ORLANDO, Fla. – As patients learn more about alternative therapies, one glaucoma specialist still recommends medication first, then elevating low systemic blood…
FDA News

FDA approves Pataday eye allergy products for OTC use

February 17, 2020
Alcon’s Pataday Once Daily Relief and Pataday Twice Daily Relief products, both designed to temporarily relieve ocular itching due to pollen and other allergens…
Perspectives on GlaucomaPerspective

Myopic eyes with untreated NTG may progress slowly

February 4, 2020
The progression rate of normal tension glaucoma with myopia may be slow even without the uses of glaucoma medications, according to findings published in the American
More Headlines »
CME

Visual Reality: Diabetic Retinopathy

This activity is supported by independent medical education grants from Optos North America and Regeneron Pharmaceuticals, Inc.

More »
Video

VIDEO: Penicillins most commonly prescribed orals in eye care

May 31, 2018
More »
Video
Meeting News

VIDEO: Prescribe opioids when appropriate

December 11, 2019
More »